ArticlePDF Available

Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs

Authors:
  • University of Szeged and Eötvös Loránd Research Network (ELKH)

Abstract and Figures

The species-specific determinants of repolarization are poorly understood. This study compared the contribution of various currents to cardiac repolarization in canine and human ventricle. Conventional microelectrode, whole-cell patch-clamp, molecular biological and mathematical-modelling techniques were used. Selective IKr-block (50 100 nmol/L dofetilide) lengthened APD90>3-fold more in human than dog, suggesting smaller repolarization-reserve in humans. Selective IK1-block (10-µmol/L BaCl2) and IKs block (1-μmol/L HMR-1556) increased APD90 more in canine than human right-ventricular papillary muscle. Ion-current measurements in isolated cardiomyocytes showed that IK1- and IKs-density were 3- and 4.5-fold larger in dogs than humans respectively. IKr-density and kinetics were similar in human versus dog. ICa and Ito were respectively ~30% larger and ~29% smaller in human, and Na+,Ca2+-exchange current was comparable. Cardiac mRNA-levels for the main IK1 ion-channel subunit Kir2.1 and the IKs accessory-subunit minK were significantly lower, but mRNA-expression of ERG and KvLQT1 (IKr and IKs α-subunits) were significantly higher in human versus dog. Immunostaining suggested lower Kir2.1 and minK, and higher KvLQT1 protein-expression in human versus canine cardiomyocytes. IK1 and IKs inhibition increased the APD-prolonging effect of IKr-block more in dog (by 55% and 51% respectively) than human (33 and 16%), indicating that both currents contribute to increased repolarization-reserve in the dog. A mathematical model incorporating observed human-canine ion-current differences confirmed the role of IK1 and IKs in repolarization-reserve differences. Thus, humans show greater repolarization-delaying effects of IKr-block than dogs, because of lower repolarization-reserve contributions from IK1 and IKs, emphasizing species-specific determinants of repolarization and the limitations of animal models for human disease.
The voltage dependence of the activation and deactivation kinetics of human and canine IKr and IKs  A, voltage dependence of activation kinetics. IKr and IKs were activated by test pulses with durations from 10 to 5000 ms, to test potentials ranging from 0 to 50 mV; then the cells were clamped back to −40 mV. The amplitudes of tail currents as a function of the duration of the depolarization were well fitted by single exponentials. B, the voltage dependence of IKs deactivation kinetics was determined by activating IKs with 5000 ms test pulses to 50 mV from a holding potential of −40 mV. Then the cells were clamped back for 2 s to potentials ranging from −50 to 0 mV (pulse frequency 0.1 Hz) and the deactivation time course of the tail current was fitted by a single exponential function. C, the voltage dependence of IKr deactivation kinetics was determined by activating IKr with 1000 ms test pulses to 30 mV from a holding potential of −40 mV. Then the cells were clamped for 16 s to potentials ranging from −70 to 0 mV (pulse frequency 0.05 Hz) and the deactivation time course of the tail current was fitted by a double exponential function. The left panel shows the voltage dependence of slow and fast time constants. An expanded version of the results for voltage dependence of the fast time constants is provided in the right bottom panel. The right top panel shows the relative amplitudes of the fast and slow components at different voltages in dog (black) and human (red) ventricular myocytes.
… 
Content may be subject to copyright.
J Physiol 591.17 (2013) pp 4189–4206 4189
The Journal of Physiology
Ionic mechanisms limiting cardiac repolarization reserve
in humans compared to dogs
Norbert Jost1,2,L
´
aszl ´
oVir
´
ag2, Philippe Comtois10,11,Bal
´
azs ¨
Ord¨
og2,9,Vikt´
oria Szuts2,Gy
¨
orgy Sepr´
enyi3,
Mikl ´
os Bitay4,Zs´
ofia Kohajda1,Istv
´
an Koncz2,NorbertNagy
1,Tam
´
as Sz´
el1,J
´
anos Magyar7,M
´
aria Kov´
acs2,
L´
aszl ´
oG.Pusk
´
as6, Csaba Lengyel2,5, Erich Wettwer8,UrsulaRavens
8,P
´
eter P. N´
an´
asi7,JuliusGy.Papp
1,2,
Andr´
as Varr ´
o1,2and Stanley Nattel9,11
1Division of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary
Departments of 2Pharmacology and Pharmacotherapy, 3Medical Biology, and 4Cardiac Surgery, Faculty of Medicine, University of Szeged, Szeged,
Hungary
5First Department of Internal Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary
6Laboratory for Functional Genomics, Biological Research Center, Hungarian Academy of Sciences, Szeged, Hungary
7Department of Physiology, Faculty of Medicine, University of Debrecen, Hungary
8Department of Pharmacology and Toxicology, Dresden University of Technology, Germany
Department of 9Medicine and 10Physiology, Universit´
edeMontr
´
eal, Quebec, Canada
11Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
Key points
Cardiac repolarization, through which heart-cells return to their resting state after having fired,
is a delicate process, susceptible to disruption by common drugs and clinical conditions.
Animal models, particularly the dog, are often used to study repolarization properties and
responses to drugs, with the assumption that such findings are relevant to humans. However,
little is known about the applicability of findings in animals to man.
Here, we studied the contribution of various ion-currents to cardiac repolarization in canine
and human ventricle.
Humans showed much greater repolarization-impairing effects of drugs blocking the
rapid delayed-rectifier current IKr than dogs, because of lower repolarization-reserve
contributions from two other important repolarizing currents (the inward-rectifier IK1 and
slow delayed-rectifier IKs).
Our findings clarify differences in cardiac repolarization-processes among species, highlighting
the importance of caution when extrapolating results from animal models to man.
Abstract The species-specific determinants of repolarization are poorly understood. This
study compared the contribution of various currents to cardiac repolarization in canine and
human ventricle. Conventional microelectrode, whole-cell patch-clamp, molecular biological and
mathematical modelling techniques were used. Selective IKr block (50–100 nmol l1dofetilide)
lengthened AP duration at 90% of repolarization (APD90)>3-fold more in human than dog,
suggesting smaller repolarization reserve in humans. Selective IK1 block (10 μmol l1BaCl2)and
IKs block (1 μmol l1HMR-1556) increased APD90 more in canine than human right ventricular
papillary muscle. Ion current measurements in isolated cardiomyocytes showed that IK1 and IKs
densities were 3- and 4.5-fold larger in dogs than humans, respectively. IKr density and kinetics
were similar in human versus dog. ICa and Ito were respectively 30% larger and 29% smaller
in human, and Na+–Ca2+exchange current was comparable. Cardiac mRNA levels for the main
N. Jost and L. Vir´
ag contributed equally to this work. Both are to be
considered first authors. A. Varr´
o and S. Nattel share senior authorship.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society DOI: 10.1113/jphysiol.2013.261198
4190 N. Jost and others J Physiol 591.17
IK1 ion channel subunit Kir2.1 and the IKs accessory subunit minK were significantly lower, but
mRNA expression of ERG and KvLQT1 (IKr and IKs α-subunits) were not significantly different,
in human versus dog. Immunostaining suggested lower Kir2.1 and minK, and higher KvLQT1
protein expression in human versus canine cardiomyocytes. IK1 and IKs inhibition increased the
APD-prolonging effect of IKr block more in dog (by 56% and 49%, respectively) than human
(34 and 16%), indicating that both currents contribute to increased repolarization reserve in
the dog. A mathematical model incorporating observed human–canine ion current differences
confirmed the role of IK1 and IKs in repolarization reserve differences. Thus, humans show greater
repolarization-delaying effects of IKr block than dogs, because of lower repolarization reserve
contributions from IK1 and IKs , emphasizing species-specific determinants of repolarization and
the limitations of animal models for human disease.
(Received 26 June 2013; accepted after revision 16 July 2013; first published online 22 July 2013)
Corresponding author A. Varr ´
o: Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University
of Szeged, H-6720 Szeged, D´
om t´
er 12, PO Box 427, Hungary. Email: varro.andras@med.u-szeged.hu
Abbreviations AP, action potential; APD, action potential duration; ICaL ,L-typeCa
2+current; IK1,inwardrectierK
+
current; IKr, rapid delayed-rectifier K+current; IKs , slow delayed-rectifier K+current; Ito, transient-outward current;
NCX,Na
+–Ca2+exchanger current.
Introduction
Many drugs can affect transmembrane K+currents
and thereby cause therapeutically useful (Honhloser
& Woosley, 1994; Brendorp et al. 2001) or harmful
(Surawicz, 1989; El-Sherif, 1992) effects. Blocking cardiac
K+channels prolongs repolarization and refractoriness,
producing Class III antiarrhythmic effects both in
ventricles and atria (Sing & Vaughan-Williams, 1970).
Excessive lengthening of repolarization may induce
life-threatening ventricular tachyarrhythmias like torsades
de pointes (Hondeghem & Snyders, 1990; El-Sherif, 1992).
Predicting the risk of such serious side effects is a major
challenge in cardiac safety pharmacology. Torsade-risk
estimation is hampered by a lack of easily usable methods
and by incomplete understanding of the repolarization
process in both experimental animals and humans.
Repolarization is controlled by two major inward
currents (Na+and Ca2+) and four major outward
K+currents (rapid and slow delayed-rectifier (IKr and
IKs), transient-outward (Ito )andinward-rectier(IK1)
currents), as well as other less well-characterized currents,
electrogenic pumps and exchangers (Nerbonne & Kass,
2005). According to the concept of ‘repolarization reserve’
(Roden, 1998), normal repolarization is accomplished by
multiple different potassium channels providing a strong
safety reserve for repolarization. Thus, in normal cardiac
tissue the pharmacological block or impairment of a
single type of potassium channel does not necessarily
lead to marked QT interval prolongation. However, in
situations where the density of one or more types of
potassium channels is decreased by congenital disorders or
remodelling, inhibition of other potassium channels may
lead to unexpectedly augmented action potential duration
(APD) prolongation resulting in proarrhythmic reactions.
In genetic channelopathies certain potassium channels,
which normally contribute to repolarization, can attenuate
the capability of the heart to repolarize (Biliczki et al. 2002;
Jost et al. 2005).
Transmembrane ion currents flow through channel
complexes composed of α-andβ-subunit proteins
including ERG (encoded by KCNH2 ), minK (KCNE 1),
MiRP1–4 (KCNE25), KvLQT1 (KCNQ1), Kv4.3 (KCND3 ),
Kv1.4 ( KCNA4), KChIP2 (KCNIP2) and Kir2.1–2.4
(KCN J2,KCNJ12 ,KCNJ4, KCNJ14 ). These proteins are
abundantly expressed in mammalian hearts, but their
relative contributions vary considerably among species
(Varr ´
oet al. 2000; Zicha et al. 2003). Differential K+
current expression causes interspecies differences in the
response to K+channel blocking drugs, affecting pre-
dictive value for their effects in humans (Nerbonne &
Kass, 2005). Despite the very common use of the dog in
evaluating long-QT risk in man, there is little quantitative
information available about the relative responses of
human versus canine hearts to QT-prolonging inter-
ventions or regarding underlying differences in ionic
currents. Here, we compared the contribution of three
particularly important K+currents, IKr ,IK1 and IKs,to
repolarization in dog and human hearts, studied the
molecular basis of differences observed, and analysed their
importance with a mathematical model.
Methods
For methodological details, please see Supplemental
Methods.
Ethical approval and species
Patients. Hearts were obtained from organ donors
whose non-diseased hearts were explanted to obtain
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
J Physiol 591.17 Weak IK1,IKs limit human repolarization reserve 4191
pulmonary and aortic valves for transplant surgery.
Before cardiac explantation, organ donors did not receive
medication apart from dobutamine, furosemide, and
plasma expanders. The investigations conformed to the
principles of the Declaration of Helsinki. Experimental
protocols were approved by the University of Szeged
and National Scientific and Research Ethical Review
Boards (Nos. 51-57/1997OEj and 4991-0/2010-1018EKU
(339/PI/010)). After explantation, each heart was perfused
with cardioplegic solution (for contents see Online Data
Supplement) and kept cold (4–6C) for 2–4 h prior to
dissection.
Animals. All experiments complied with the Guide for
the Care and Use of Laboratory Animals (NIH publication
No 85-23, revised 1985). The protocols were approved
by the Review Board of the Department of Animal
Health and Food Control of the Ministry of Agriculture
and Rural Development, Hungary (XII./01031/000/2008
and XIII./1211/2012). Adult mongrel dogs of either sex
weighing 8–16 kg were anaesthetized with pentobarbital
(30 mg kg1I.V.). Hearts were removed through right
lateral thoracotomies and rinsed in modified Locke’s
solution containing (mmol l1): Na+140, K+4, Ca2+
1.0, Mg2+1.0, Cl126, HCO325 and glucose 11; pH
7.35–7.45, 95% O2-5% CO2,37
C.
Action potential measurements
Action potentials (APs) were recorded in right ventricular
trabeculae and papillary muscle preparations (<2mm
diameter), from 15 non-diseased human donor hearts
(9 male and 6 female, age =44.6 ±5.9 years) and 25 dogs,
with conventional microelectrode techniques, as described
in detail previously (Varr ´
oet al. 2000; Biliczki et al. 2002;
Jost et al. 2005).
Transmembrane current measurements
Cell isolation. Ventricular cardiomyocytes were enzy-
matically dissociated from the left ventricular mid-
myocardial free wall of 10 additional non-diseased human
donor hearts (5 male and 5 female, age =43.4 ±5.3 years)
and 21 dog hearts with previously described procedures
(Varr ´
oet al. 2000; Biliczki et al. 2002; Jost et al. 2005).
Experimental protocol. Rod-shaped, striated cardio-
myocytes were placed in a recording chamber on the
stage of inverted microscopes Olimpus, IX51 (Olympus
Ltd, Tokyo, Japan) and Nikon TMS (Nikon Ltd, Tokyo,
Japan) and allowed to adhere. The solutions, equipment
and voltage-clamp protocols (see Supplemental Methods)
were as previously detailed for K+currents (Varr ´
oet al.
2000; Biliczki et al. 2002; Jost et al. 2005) and for L-type
Ca2+current (ICaL)andNa
+–Ca2+exchanger (NCX)
current (Hobai et al. 1997; Birinyi et al. 2005).
Molecular biology
Reverse transcription (RT) quantitative polymerase chain
reaction (qPCR). Left ventricular midmyocardial free-wall
samples were obtained from eight human (7 male and
5 female, age =45.2 ±3.7 years) and eight dog hearts,
and snap-frozen in liquid N2. RNA was isolated with
the Qiagen RNase Tissue kit (Amersham). Reverse
transcription (RT) was performed with Superscript-II
RNase H-Reverse Transcriptase (Invitrogen). QPCR
was performed on a RotorGene-3000 instrument
(Corbett Research, Australia) with gene-specific primers
(Supplemental Table 1) and SybrGreen. Expression
values were normalized to β-actin. Triplicate standard
curves were run for each experiment. Data analysis
was performed with the Pfaffl method (Pfaffl, 2001),
correcting for amplification efficiency differences.
Western blot. Membrane proteins were obtained from
the same samples used for qPCR. Samples were suspended
in lysis buffer, dounced and centrifuged (2000 ×g,10min,
4C). The supernatant was resuspended in lysis buffer
containing 2% Triton X-100. After 1.5 h incubation
on ice, samples were ultracentrifuged (100 000 ×g,
35 min, 4C), supernatants collected and stored at
70C. Protein concentration was measured by the
Lowry method and samples diluted in loading buffer
for SDS–polyacrylamide gel electrophoresis. Fractionated
proteins were transferred onto polyvinylidine difluoride
(PVDF) membranes, blocked in Tris buffer supplemented
with Tween-20 (TBST) and 10% non-fat milk (BioRad,
USA), then incubated overnight (4C) with rabbit
polyclonal primary antibodies against Kir2.1, Kir2.2,
Kir2.3, ERG, minK and KvLQT1, goat anti-Kir2.4
(Santa Cruz Biotechnology) or mouse monoclonal
anti-α-sarcomeric actin (DAKO). Bound primary anti-
bodies were detected with anti-rabbit, anti-goat or
anti-mouse secondary antibodies conjugated to horse-
radish peroxidase. Immunoreactivity was visualized
with enhanced chemoluminescence and analysed with
ImageJTM. All values were quantified relative to internal
controls on the same samples (α-actin for Kir2.x, KvLQT1
and minK, GAPDH for ERG).
Immunohistochemistry. Isolated dog (n=6) and human
(3 male, 1 female, age =48.3 ±4.7 years) left ventricular
midmyocardial free-wall ventricular cardiomyocytes on
glass coverslips were fixed with acetone. Samples were
rehydrated with calcium-free phosphate-buffered saline
(PBS) and blocked for 2 h with PBST (PBS with
0.01% Tween) containing 1% BSA at room temperature.
Incubation with the primary polyclonal rabbit anti-
body for 1.5 h at room temperature was followed by
1 h incubation with secondary antibodies (Alexafluor
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
4192 N. Jost and others J Physiol 591.17
448-conjugated goat anti-rabbit IgG). Control samples
were incubated only with secondary antibody.
Fluorescence images were obtained with an Olympus
FV1000 confocal laser-scanning microscope and
standardized parameter settings. Images were quantified
in greyscale TIFF format with ImageQuantTM software.
On each image, three to five random strips were selected
and fluorescence profiles plotted. Baseline pixels were
identified and subtracted from total profile area.
Statistics. Results are expressed as means ±SEM.
Statistical significance was determined by two-tailed
Student’s ttests and ANOVA with Bonferroni-corrected
post hoc t tests as appropriate. Results were considered
significant for P<0.05.
Results
Current densities
IK1 was recorded with 300 ms 0.33 Hz test pulses from
a holding potential of 80 mV (Fig. 1A) and quantified
based on end-pulse amplitude. IK1 was significantly larger
in dog than human cardiomyocytes (Fig. 1B). Maximum
outward current density at 60 mV was almost 3-fold
greater in dog versus human (1.72 ±0.07 pA pF1vs.
0.65 ±0.1 pA pF1,n=21–28, Fig. 1C).
Mean IKr and IKs data are shown in Fig. 2. IKr data
are shown in panels A–C and IKs data in panels D–F.
Examples of original IKr recordings are in the top row,
and IKs recordings in the middle row. IKr tail current at
40 mV after 1000 ms test pulses (0.05 Hz) did not differ
significantly between species (Fig. 2C). In contrast, IKs tail
current at 40 mV after 5000 ms test pulses (0.1 Hz) was
about 4.5-fold larger in dog versus human (Fig. 2F).
To estimate the magnitude of IK1 ,IKr and IKs activated
during the cardiac action potential, we compared the
amplitudes of the BaCl2-sensitive (IK1), E-4031-sensitive
(IKr) and L-735,821-sensitive (IKs) currents during ‘action
potential’ test pulses. These test pulses were obtained
by digitizing representative right ventricular human and
canine action potentials recorded with conventional
microelectrodes (Fig. 3A). Under these conditions, the
BaCl2-sensitive IK1 difference current flowing during
the AP was substantially larger in dog than in human
(Fig. 3B), while the E-4031-sensitive IKr difference
current was similar (Fig. 3C). The L-735,821-sensitive
IKs during the action potential plateau phase was very
small and not clearly different between the two species
(Fig. 3D).
The activation and deactivation kinetics of IKr and IKs
measured at the whole range of activating and deactivating
membrane potentials are shown in Fig. 4. The IKs kinetics
of human and dog are quite similar (Fig. 4Aand B). IKr
Figure 1. Inward-rectifier potassium current (IK1) in human and dog ventricular cardiomyocytes
A, original IK1 recordings in a human (top traces) and a dog (bottom traces) ventricular myocyte. Voltage protocol
shown above traces. B, mean ±SEM IK1 density–voltage relations. C, mean ±SEM IK1 density at 60 mV (left)
and 140 mV (right) membrane potentials. P<0.05, ∗∗P<0.01 dog versus human. n=number of experiments.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
J Physiol 591.17 Weak IK1,IKs limit human repolarization reserve 4193
deactivation (Fig. 4C) at voltages (70 and 60 mV)
relevant to physiological current deactivation (i.e. near
the resting potential) consisted predominantly of a rapid
phase with a time constant of 200–400 ms, not significantly
different between human and dog. At more positive
voltages, the kinetics became more clearly biexponential.
The rapid-phase time constants were similar at all voltages
for human and dog. At voltages negative to 30 mV, the
slow-phase time constant was also similar, whereas at more
positive voltages the slow-phase time constant was greater
in dog.
Species-dependent contributions of IK1,IKr and IKs to
repolarization
The contribution of IK1,IKr and IKs to repolarization was
investigated (Fig. 5) by selectively blocking these currents
with BaCl2(10 μmol l1), dofetilide (50 nmol l1)and
HMR-1556 (1 μmol l1), respectively. We previously
reported that 10 μmol l1BaCl2blocks over 70% of IK1
without affecting IKr ,IKs and Ito (Biliczki et al. 2002). In
human ventricular muscle, selective inhibition of IK1 only
marginally prolonged AP duration (APD, by 4.8 ±1.5%),
Figure 2. IKr and IKs in human and dog ventricular cardiomyocytes
Aand B, original IKr recordings from a human (A) and a dog (B) ventricular cardiomyocyte. C, mean ±SEM IKr
tail current density–voltage relations. Dand E, original IKs recordings from a human (A) and a dog (B) ventricular
cardiomyocyte. F, mean ±SEM IKs tail current density–voltage relations. n=number of experiments. P<0.05,
∗∗P<0.01 and ∗∗∗ P<0.001.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
4194 N. Jost and others J Physiol 591.17
while it caused significant APD prolongation in dog
(17.9 ±2.1%, P<0.05 vs. human, n=7–11). In contrast,
selective inhibition of IKr caused markedly greater APD
prolongation in humans (56.3 ±8.4%) compared to the
dog (21.7 ±2.5%, P<0.05, n=17–20). The differential
response was due to differences in maximal effects and not
drug sensitivity per se, as shown by similar dofetilide IC50
values between species (Supplemental Fig. 1). IKs block
did not significantly alter APD in either studied species.
Contributions to repolarization reserve
We then studied the role of IK1 and IKs differences
in contributing to the larger APD increases produced
by IKr block in human versus canine cardiomyocytes.
Tissues were exposed to dofetilide in the absence or pre-
sence of 10 μmol l1BaCl2to inhibit IK1 (Fig. 6A)or
HMR-1566 to block IKs (Fig. 6B). The change in APD
(relative to BaCl2-free control) caused by dofetilide alone
indicates the effect of the drug with repolarization reserve
intact, whereas the change caused in the presence of
BaCl2(dofetilide +BaCl2vs. BaCl2alone) indicates the
effect with IK1 suppressed, i.e. the contribution of IK1 to
repolarization reserve. In human cells, dofetilide increased
APD by 59 ±5% in the presence of BaCl2,versus 44 ±4%
in the absence of BaCl2. The relative increase from 44%
prolongation with IK1 intact to 59% prolongation with IK1
removed indicates a 34% increase in IKr blocking effect
with IK1 suppressed. For dog cells, dofetilide increased
Figure 3.
A, currents recorded with action potential voltage-clamp waveforms, obtained by recording typical normal human
or canine ventricular action potentials with a conventional microelectrode in a multicellular papillary muscle
preparation. B–D, original BaCl2(IK1, purple recordings, B), E-4031 (IKr, red recordings, C) and L-735,821 (IKs,
green recordings, D) sensitive currents obtained by digitally subtracting currents elicited by action potential test
pulses in the presence of the blocker from current in the same cell prior to the blocker in human (left panels) and
dog (middle panels) ventricular myocytes. Right panels represent corresponding mean amplitudes of drug-sensitive
IK1,IKr and IKs currents in 4–13 cells per measurement. Arrows indicate the points at which current amplitudes
were determined. Bars represent means ±SEM; corresponding nvalues are provided for each current and species.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
J Physiol 591.17 Weak IK1,IKs limit human repolarization reserve 4195
APD by 25 ±2% in the presence of BaCl2,versus 16 ±2%
in the absence of BaCl2, indicating a 56% increase in IKr
blocking effect with IK1 suppression. This result confirms
a larger contribution of IK1 to repolarization reserve in
the dog versus man. For IKs (Fig. 6B), dofetilide increased
APD by 63 ±4% in the absence of HMR-1566-induced
IKs block in humans, versus 73 ±2% in the presence of
HMR-1566, an increase of 16% attributable to the loss
of the IKs contribution. In the dog, dofetilide prolonged
APD by 29 ±5% in the absence of HMR-1566, versus
43 ±4% in its presence, indicating a 49% enhancement
attributable to loss of IKs. Thus, the larger IKs of canine
tissues also contributes to greater repolarization reserve
versus humans.
Ion channel subunit expression
To assess the potential molecular basis for the observed
differences in IK1 and IKs densities, qPCR was applied
for subunits underlying IK1,IKr and IKs . Gene expression
values for IK1-encoding subunits are shown in Fig. 7A.
Kir2.1-encoding mRNA (KCNJ2 )was>2-fold more
abundant in the dog than the total mRNA level for Kir2.1,
Figure 4. The voltage dependence of the activation and deactivation kinetics of human and canine IKr
and IKs
A, voltage dependence of activation kinetics. IKr and IKs were activated by test pulses with durations from 10 to
5000 ms, to test potentials ranging from 0 to 50 mV; then the cells were clamped back to 40 mV. The amplitudes
of tail currents as a function of the duration of the depolarization were well fitted by single exponentials. B,the
voltage dependence of IKs deactivation kinetics was determined by activating IKs with 5000 ms test pulses to
50 mV from a holding potential of 40 mV. Then the cells were clamped back for 2 s to potentials ranging from
50 to 0 mV (pulse frequency 0.1 Hz) and the deactivation time course of the tail current was fitted by a single
exponential function. C, the voltage dependence of IKr deactivation kinetics was determined by activating IKr
with 1000 ms test pulses to 30 mV from a holding potential of 40 mV. Then the cells were clamped for 16 s
to potentials ranging from 70 to 0 mV (pulse frequency 0.05 Hz) and the deactivation time course of the tail
current was fitted by a double exponential function. The left panel shows the voltage dependence of slow and fast
time constants. An expanded version of the results for voltage dependence of the fast time constants is provided
in the right bottom panel. The right top panel shows the relative amplitudes of the fast and slow components at
different voltages in dog (black) and human (red) ventricular myocytes.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
4196 N. Jost and others J Physiol 591.17
Kir2.2, Kir2.3 and Kir2.4 combined in the human. The
KCN H2 gene encoding IKr was equivalently expressed
in canine and human ventricle (Fig. 7B). KCNQ1 gene
expression was not significantly different between human
and dog (Fig. 7C), but the KCNE1 gene encoding the
IKs β-subunit protein minK was 6-fold more strongly
expressedindog.ExamplesofWesternblotsforKir2.x,
ERG, KvLQT1 and minK proteins are shown in Fig. 7D–F.
Mean data are provided in Table 1. In agreement with
qPCR-findings, Kir2.1 was significantly stronger in canine
than human hearts, whereas Kir2.2 was stronger in
humans. ERG was detected as two larger molecular
mass bands (Fig. 7E) corresponding to ERG1a (150
and 165 kDa) and two smaller bands corresponding to
ERG1b (85 and 95 kDa). ERG1a was less abundant
in human samples, while ERG1b band intensities were
not significantly different from dogs. The very similar
expression of ERG1b, in agreement with physiological
data (Figs 2Cand 3), is consistent with recent evidence
for a particularly important role of ERG1b in forming
functional IKr (Sale et al. 2008) and with a recent study
of Purkinje fibre remodelling with heart failure (Maguy
et al. 2009). MinK bands were also stronger in dog
hearts, whereas KvLQT1 band intensity was greater in
human.
We also performed immunohistochemical analyses on
isolated cardiomyocytes (Fig. 8), with identical image
settings for human versus canine cells. Examples are shown
in Fig. 8A. Anti-Kir2.1 showed significantly stronger
staining for canine cells (Fig. 8B), and Kir2.3 staining
was also slightly but significantly greater for dog. In
contrast, ERG staining was comparable for the two species
(Fig. 8C). KvLQT1 staining was modestly but significantly
greater for human cells (Fig. 8D), but in keeping
with the qPCR data, mink staining was much greater
(5-fold) for dog cells versus human. Supplemental
Fig. 2 presents negative controls for immunostaining
measurements.
Figure 5. Effect of selective IK1 (10 μMBaCl2), IKr (50 nmol l1dofetilide) or IKs (1 μmol l1HMR-1566)
block on APs measured with standard microelectrode techniques in canine and human right papillary
muscles
A, recordings (at 1 Hz) before and after 40 min superfusion with BaCl2(left), dofetilide (middle) or HMR-1566
(right). Corresponding mean±SEM values for controls (C) and drug (D) effects are given under each action potential
recordings. B, mean ±SEM AP duration at 90% of repolarization (APD90 ) under each condition. n=number of
experiments, ∗∗P<0.01 and ∗∗∗ P<0.001.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
J Physiol 591.17 Weak IK1,IKs limit human repolarization reserve 4197
Other ionic current differences and in silico
assessment
The functional, pharmacological, and biochemical data
described above all point to reduced repolarization reserve
due to smaller IKs and IK1 expression in human hearts
as the basis for their larger APD prolonging response to
IKr inhibition. To assess the potential role of other ionic
current differences, we compared several other currents
between canine and human hearts. Ito,recordedasthe
difference between peak and end-pulse current during
300 ms depolarizing pulses from 90 mV (0.33 Hz), was
smaller in human versus dog (Fig. 9A). ICaL evoked by
400 ms test pulses from 40 mV was 30% larger in
human (Fig. 9B). Recovery kinetics of Ito (Supplemental
Fig. 3A)andICa (Supplemental Fig. 3B) currents were
not statistically different in myocytes from human and
dog ventricle. Ni2+(10 mmol l1)-sensitive NCX current
was not significantly different between species (Fig. 9C
and D).
To assess the contribution of ionic current components
to repolarization reserve in human versus canine hearts, we
initially adapted the Hund–Rudy dynamic (HRd) canine
ventricular AP model (Hund & Rudy, 2004). We then
adjusted the current densities in the dog model according
to the experimentally observed differences in humans,
to obtain ‘humanized’ APs (see Supplemental Methods).
Supplemental Fig. 4 shows the resulting simulations:
APD90 at 1 Hz in the dog model was 209 ms, versus human
264 ms, close to experimentally determined values (APD90
at 1 Hz: dog 227 ms, human 270 ms). IKr block increased
APD90 by 26% in the human AP model (Supplemental Fig.
4A)versus 15.5% in the dog model (Supplemental Fig. 4B),
Figure 6. Effect of combined IKr +IK1 and IKr +IKs inhibition in human and dog ventricular muscle pre-
parations (endocardial impalements)
A, representative APs at baseline (circle), following exposure to 10 μmol l1BaCl2(triangle), 50 nmol l1dofetilide
(diamond), and combined 10 μmol l1BaCl2+50 nmol l1dofetilide (rectangle) in human (top traces) and
dog (bottom traces) ventricular muscle. Brackets show average differences between conditions indicated. B,
representative APs at baseline (circle), following exposure to 1 μmol l1HMR-1566 (triangle), 50 nmol l1
dofetilide (diamond), and combined 1 μmol l1HMR-1566 +50 nmol l1dofetilide (rectangle) in human (top
traces) and dog (bottom traces) ventricular muscle. Brackets show average differences between conditions
indicated.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
4198 N. Jost and others J Physiol 591.17
qualitatively consistent with experimental findings (56%,
22% respectively). IKr inhibition increased human APD90
by 71.2% in the presence of IK1 block, indicating a 173.8%
increase in IKr blocking effect with the IK1 contribution to
repolarization reserve suppressed (Supplemental Fig. 4A).
For the canine model (Supplemental Fig. 4B), IKr block
increased APD90 by 45.4% in the presence of IK1 block,
indicating a 193.5% increase in IKr blocking effect
when IK1 is decreased. This result is consistent with
experimental data suggesting a larger contribution of IK1
to repolarization reserve in the dog. IKr block prolonged
human APD90 by 29.4% (Supplemental Fig. 4C)inthepre-
sence of IKs inhibition, an increase of 14.6% attributable
to the loss of IKs contribution to repolarization reserve.
ForthedogAPmodel(SupplementalFig.4D), IKr
block prolonged APD by 23.8% in the presence of IKs
inhibition, indicating a 53.6% enhancement attributable
to loss of the repolarization reserve effect of IKs. Thus,
the model also confirms the importance of larger IKs to
greater repolarization reserve in dogs. Finally, we used
the model to explore the contributions of ICaL and Ito
differences. Supplemental Fig. 5 shows the APD changes
induced by IKr inhibition in canine (panel A) and human
(panel B) models. The effect of IKr inhibition in the
human model was then verified with ICaL (panel C)or
Ito (panel D) modified to canine values. APD90 increases
in the human model resulting from IKr inhibition were
minimally affected by substituting canine Ito in the human
model. Substituting canine ICaL into the human model
enhanced the IKr blocking effect on APD, whereas if
canine ICaL contributed to the larger repolarization reserve
in the dog it should reduce the APD prolonging effect.
These results indicate that ICaL and Ito differences do not
contribute to the enhanced repolarization reserve in the
dog.
To assess further the contribution of ionic current
components to repolarization reserve in human versus
canine hearts, we performed the analysis in a reverse
Figure 7. Expression of IK1-related (Kir2.x), IKr
pore-forming (ERG) and IKs-related subunits
(KvLQT1 and minK)
AC, mean ±SEM mRNA levels of Kir2.x (A), ERG
(B) and KvLQT1/minK (C) subunits in left
ventricular human (n=6–8) and dog (n=816)
preparations. P<0.05, ∗∗P<0.01 and
∗∗∗P<0.001. n=number of experiments. DF,
representative Western blots for Kir2.x (D), ERG
(E) and KvLQT1/minK (F) in human and dog left
ventricular preparations.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
J Physiol 591.17 Weak IK1,IKs limit human repolarization reserve 4199
Table 1. Protein expression data for ion channel subunits in human versus dog ventricular tissues
Currents/subunits SubunitHumanDog
IK1 subunits Kir2.1 (n=4/4) 0.22 ±0.01 0.45 ±0.06
Kir2.2 (n=4/4) 0.64 ±0.03∗∗ 0.37 ±0.02
Kir2.3 (n=4/4) 0.10 ±0.01 0.09 ±0.007 (P=NS)
Kir2.4 (n=4/4) 0.01 ±0.002 0.20 ±0.009∗∗
IKr subunits ERG1a (n=5/4) 0.30 ±0.16 0.97 ±0.27∗∗
ERG1b (n=5/4) 0.71 ±0.05 0.73 ±0.07 (P=NS)
IKs subunits KvLQT1 (n=4/4) 0.15 ±0.01∗∗ 0.05 ±0.003
MinK (n=4/4) 0.31 ±0.01 0.40 ±0.05
Mean ±SEM data. P<0.05, ∗∗P<0.01, ∗∗∗ P<0.001. ndesignates number of samples from humans/dogs.
All values are expressed as arbitrary optical density units, quantified relative to an internal control on the same
sample (α-actin for Kir2.x, KvLQT1 and minK, GAPDH for ERG).
fashion, with the more recently published O’Hara–Rudy
dynamic (ORd) human ventricular AP model (O’Hara
et al. 2011, see Supplemental Methods). Figure 10 shows
the resulting simulations: APD90 at 1 Hz in the canine
and human models were 210 ms and 271 ms (versus
experimental APD90 at 1 Hz: dog 227 ms, human 270 ms).
IKr block increased APD90 by 42.4% in the human versus
29.4% in the dog model, consistent with experimental
findings (56%, 22% respectively). With the human ionic
model (Fig. 10A), IKr block increased APD by 58.7% in
the presence of IK1 block, versus 42.4% in the absence
of IK1 block. These results indicate a 38.3% increase in
IKr blocking effect on APD with IK1 blocked. For the dog
ionic model (Fig. 10B), IKr block increased APD by 45.8%
in the presence of IK1 block, versus 29.4% in the absence
of IK1 block, indicating a 55.7% increase in IKr blocking
effect when IK1 was decreased. This result confirms the
notion based on our experimental data, indicating a larger
contribution of IK1 to repolarization reserve in the dog
compared to man. IKr block increased APD by 42.4% in the
absence of IKs block in the human model (Fig. 10C), versus
50.3% in the presence of IKs block, an increase of 18.5%
attributable to the loss of IKs contribution torepolarization
reserve. In the dog ionic model (Fig. 10D), IKr block
prolonged APD by 29.4% in the absence of IKs block, versus
46.9% in its presence, indicating a 59.4% enhancement
attributable to loss of the repolarization reserve effect of
IKs. Thus, the model also confirms the importance of larger
IKs to greater repolarization reserve in dogs. Finally, we also
used this modelling approach to explore the contributions
of ICaL and Ito differences, and found no evidence that they
contribute to the differences in IKr blocking effects between
human and dog (Supplemental Fig. 6).
Discussion
In this study, we found that IKr inhibition causes
substantially greater APD prolongation in human
versus canine ventricular muscle, indicating reduced
repolarization reserve in man. Ionic current
measurements showed larger IK1 and IKs densities
in canine versus human hearts and APD studies with
selective blockers indicated larger repolarization reserve
in canine hearts due to stronger IK1 and IKs contributions.
Expression studies suggested that the ionic current
differences are due to species-related differences in mRNA
expression of underlying subunits.
Experimental model considerations
We compared experimental data between non-diseased
human donor hearts and canine hearts. There is a
potential difference in relative maturity/age between the
humans and dogs that provided our tissue samples, which
were essentially impossible to control, other than by
virtue of the fact that both study populations comprised
adult and not senescent individuals. Important trans-
mural and regional differences in ion channel subunit
protein expression and current densities exist within
the heart. Extrapolation of our findings to the whole
heart must therefore be cautious. We were careful to
perform all measurements in corresponding regions
of canine and human hearts to ensure comparability.
Current and mRNA/protein densities were measured
from the left ventricular midmyocardial free-wall,
but APs were recorded from right ventricular sub-
endocardial tissue. This was done both for technical
reasons (standard microelectrode recordings from left
ventricular tissue were difficult to obtain and more
likely to be contaminated by subendocardial Purkinje
fibres) and to maximize data from each human heart
by using all available tissues. We had to optimize the
information obtained from each human heart, because
functional measurements were greatly limited by the
unpredictable and infrequent availability of human
donor tissue and because of the short time window
for meaningful functional measurement after tissue
procurement. Of note, our patch-clamp/biochemical
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
4200 N. Jost and others J Physiol 591.17
results in left ventricular free-wall were fully compatible
with our AP data from right ventricular tissues, indicating
that at least for these two widely separated regions the
observations are consistent.
Relationship to previous studies of repolarizing
currents and repolarization reserve
Our data suggest important expression differences in
Kir2.x channel mRNA expression between human and
Figure 8. Immunofluorescence confocal microscope image analysis for IK1-related (Kir2.x), IKr
pore-forming (ERG) and IKs-related (KvLQT1 and MinK) subunits in left ventricular cardiomyocytes
A, representative immunofluorescence images of human (left) and dog (right) cardiomyocytes. Dark-field images
of typical human and dog ventricular cardiomyocytes are shown at the bottom. BD, mean ±SEM fluorescence
intensities for various subunits in human versus dog cardiomyocytes. Results are shown for Kir2.x (B), ERG (C)
and KvLQT1 and minK (D) subunits. n=number of experiments. P<0.05 and ∗∗∗P<0.001 for dog versus
human.Constant image-settings were maintained for each construct for all cells studied.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
J Physiol 591.17 Weak IK1,IKs limit human repolarization reserve 4201
dog ventricle. Kir2.1 expression was about 3-fold greater
in the dog than human, but Kir2.2 and Kir2.4 levels
were negligible in dogs. In human hearts, we found
Kir2.3 mRNA expression comparable with that of Kir2.1,
generally considered the principal subunit underlying
IK1 (Dhamoon & Jalife, 2005). Significant Kir2.3 protein
expression in human ventricle was also detected by
Western blot (Fig. 7D). Kir2.1 currents display strong
inward rectification, whereas Kir2.3 inward rectification
is incomplete and negative slope conductance is less steep
(Dhamoon et al. 2004). In our study, the current–voltage
relation of IK1 in dog strongly resembles that previously
reported for Kir2.1 channels, but in human cells resembles
better a mixture of Kir2.1 and Kir2.3 properties (Dhamoon
et al. 2004) corresponding to mRNA data.
Protein quantification showed lesser ERG1a abundance
in human compared to dog tissue while expression
of ERG1b was not different. A higher ERG1b:ERG1a
expression ratio in humans suggests the possibility of
different channel subunit stoichiometry in human tissue
versus dog. This difference might have two functional
consequences. First, partially due to the accelerated
activation kinetics of heteromeric channels compared
to homomeric channels consisting of ERG1a only, the
relative contribution of IKr to the repolarization reserve
is expected to be higher in humans (Sale et al. 2008;
Larsen & Olesen, 2010). Secondly, ERG1a–ERG1b sub-
unit stoichiometry could also affect drug binding affinity
of dofetilide to IKr channels, as slightly higher IC50
values were obtained for ERG1a–1b heteromeric channels
Figure 9.
A,Ito current–voltage density (I–V relationship) relation obtained with the inset protocol. P<0.05 and +P<0.05
for human versus dog. I–V relationships for Ito are determined and depicted as peak current (open circles and
squares) and as sustained current (closed circles and squares) as well. B,ICaL current–voltage density relation
obtained with the insetprotocol. P<0.05 for human vs. dog. I–V relationships for ICa are determined and
depicted as peak current (open circles and squares) and as sustained current (closed circles and squares) as well. C,
ramp protocol was applied to measure current before and after application of Ni2+(10 mmol l1) under conditions
to isolate NCX. Representative Ni2+-sensitive difference currents from dog and human cells are shown below. D,
mean inward (at 80 mV) and outward (at +50 mV) NCX current density values.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
4202 N. Jost and others J Physiol 591.17
as compared to ERG1a homomer channels (150 nMvs.
100 nM, respectively; Abi-Gerges et al. 2011). We have
not detected any significant difference in the kinetic
behaviour of IKr in humans versus dogs and dofetilide
affinity was not different based on concentration–response
curves (Supplemental Fig. 1). Thus, relative expression on
Western blots may not reflect accurately relative local sub-
unit expression in ion channels.
Relatively little information is available about the
molecular basis of differential repolarization patterns
among species. APD prolongation and early after-
depolarization formation upon exposure to IKr blocking
drugs varies widely, with rabbits being the most sensitive,
guinea-pigs, swine and sheep the least, and dogs inter-
mediate (H. R. Lu et al. 2001). Guinea-pigs have
particularly large, and rabbits particularly small, IKs (Z.
Lu et al. 2001). This difference results from weaker
mink expression in the rabbit, despite stronger KvLQT1
expression in rabbits (Zicha et al. 2003). Interestingly,
this expression difference resembles what we observed
for human versus dog in the present study, with dogs
having much larger minK, but smaller KvLQT1, expression
than humans, along with considerably larger IKs density.
Dumaine & Cordeiro (2007) also observed larger IK1 and
IKs, along with similar IKr , for dog compared to rabbit.
MinK, on the other hand, has also been found to modulate
hERG and Kv4.3 current densities and gating of the
channels (Pourrier et al. 2003). Therefore, other currents
in addition to IKs,suchasIKr and Ito mightbepotentially
influenced by the relatively lower minK expression level in
human ventricles we found in this study.
Possible implications
Larger APD prolongation in human tissues versus dog
in response to IKr blockade, despite similar IKr,isa
novel finding that may have important implications.
Based on the present results, despite observations that
Figure 10. Simulations of effect of combined IK+IK1 and IKr +IKs inhibition on human and dog
ventricular muscle APs by applying the O’Hara dynamic (ORd) canine ventricular AP model
A, simulated human APs at control, following IK1 block (70% reduction), IKr block (50% reduction), and combined
IK1 +IKr block. B, corresponding data for dog IK1 +IKr block. C, simulated human APs at control, following IKs
block (50% reduction), IKr block (50% reduction), and combined IKs +IKr block. D, corresponding data for dog
IKs +IKr block.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
J Physiol 591.17 Weak IK1,IKs limit human repolarization reserve 4203
the properties of individual K+channels in dog resemble
those of humans (Varr ´
oet al. 2000; Jost et al. 2005),
the reserve to repolarization-delaying drugs may differ
substantially between the two species. Consequently,
the clinical repolarization-delay potential of drugs with
IKr/HERG blocking properties could be underestimated
based on experiments in dogs, and using dogs in
safety-pharmacology studies to estimate QT-lengthening
liability could be misleading. However, there is greater
similarity of individual currents in human and dog, and
better heart rate correlation between human and dog
than human and rabbit (Lengyel et al. 2001) and the
similar relative profile of rabbit versus dog K+currents
in the Dumaine–Cordeiro study (Dumaine & Cordeiro,
2007) to the human versus dog results in the present
work raise the issue of whether the commonly used,
simpler and cheaper rabbit model might be more pre-
dictive. QT prolongation by non-cardiovascular drugs is a
major problem and considerable resources are expended to
optimize QT-liability drug screening in drug development
(Vargas, 2008). Our findings have potentially important
implications for the optimization of drug screening.
Based on our data, IK1 block or downregulation/
mutation would not necessarily lead to substantial QT
prolongation in humans, unlike in the dog, but a reduction
of repolarization reserve would be expected (Roden, 1998;
Biliczki et al. 2002; Silva & Rudy, 2005; Roden, 2006).
Therefore, an IK1 (Kir2.x) channel defect due to ion
channel mutations or drug-induced malfunction may
not significantly prolong human QT intervals, but could
produce excess QT prolongation and life-threatening
torsades de pointes in the face of additional repolarization
impairment.
The present study is, to our knowledge, the first
detailed analysis of the molecular and ionic determinants
of repolarization reserve in the human heart, and the
first to compare these determinants with those of an
animal species commonly used as a model for human
cardiac electrophysiology. Our results therefore provide
novel fundamental insights into this clinically crucial
process.
Potential limitations
IK1 flows through a variety of channel subtypes that may be
constituted by different alpha-subunits including Kir2.1,
Kir2.2, Kir2.3, Kir2.4, TASK and TWIK (Wang et al. 1998;
Lopatin & Nichols, 2001; Melnyk et al. 2002; Dhamoon
et al. 2004). The latter two-pore channels do not rectify
(Lesage & Lazdunski, 2000) and were not studied in our
experiments, although their contribution to IK1 cannot
be ruled out. Previous reports indicate important species
and regional differences in relative expression of Kir2.x
proteins (Wang et al. 1998; Melnyk et al. 2002; Dhamoon &
Jalife, 2005). The densities of IK1 and distribution of Kir2.x
proteins differ in atria versus ventricles (Melnyk et al. 2002;
Dhamoon & Jalife, 2005). In the present study, we focused
on ventricular tissue exclusively. Kir2.2 has been reported
absent in rabbit ventricle but present in human (Wang
et al. 1998) and dog (Melnyk et al. 2002) ventricles. Kir2.x
proteins not only form homomeric channels, but can
also show heteromeric co-assembly (Zobel et al. 2003),
complexifying interpretation. Heteromeric assembly of
Kir2.1 and Kir2.3 proteins produces IK1 channels with
lower conductance than homomeric Kir2.1 assembly (Yan
et al. 2005; Fang et al. 2005). Since the mRNA expression
of Kir2.1 and Kir 2.3 in human ventricle was relatively
similar, unlike the dog, heteromeric Kir2.1–2.3 channels
may be more likely in the human than in the dog
ventricle, contributing to the lower IK1 density that we
observed in humans. Indirect evidence indeed points to a
significant role for heteromeric Kir2.x channels in human
IK1 (Schram et al. 2003).
All of our human samples were stored in cardio-
plegic solution following harvesting during transportation
to our facility. In preliminary studies in which we
stored canine heart samples in cardioplegic solution
and then recorded ionic currents and APs, we did not
observe any electrophysiological effects of cardioplegic
storage. Donors received haemodynamic support with
dobutamine prior to heart explantation, a ubiquitous
practice in cardiac transplantation. We cannot exclude
possible effects of dobutamine infusion on the properties
of explanted hearts.
The effects of pharmacological blockade on canine
APs vary among different laboratories. For example,
the Antzelevitch laboratory has reported larger increases
in canine ventricular APD with K+channel blockade
(Shimizu & Antzelevitch, 1999; Tsuboi & Antzelevitch,
2006) than we observed in the present study. The
discrepancies are likely to relate to differences in
experimental conditions. For this reason, it is important
that comparative studies between species responses
are produced within a single laboratory rather than
comparing changes observed for one species in one
laboratory with those for another species in a different
laboratory.
The Na+–Ca2+exchanger current (NCX) current was
defined and measured as Ni2+-sensitive current. This
approach has limitations, because it cannot be excluded
that Ni2+blocks other ionic currents. However, for
the measurement of the NCX, we blocked other ionic
currents (including K+,Na
+and Ca2+currents, along with
Na+–K+pump current) according to the experimental
approach described by Hobai et al. (1997), which is a
relative widely used method for studying NCX current
(T ´
oth et al. 2009).
The Na+–K+pump is critically dependent on extra-
and intracellular Na+and K+concentrations, voltage, sub-
cellular space and cAMP levels, and is not well explored
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
4204 N. Jost and others J Physiol 591.17
in dog and human cardiomyocytes (Fuller et al. 2013).
Since we have no experimental data regarding this current,
we cannot exclude a contribution of species difference in
the function of Na+–K+pump currents to repolarization
reserve discrepancies.
Although IKs is several-fold larger under square-wave
voltage-clamp conditions in dog than man (Fig. 2), there
was no significant difference under AP-clamp conditions
(Fig. 3). We believe that the apparent discrepancy is due to
the fact that during the normal AP, cells spend very little
time at potentials for which there is a significant difference
in IKs (positive to +20mV;Fig.2).
The enhanced density of IKs in canine versus human
heart appears to be due, at least in part, to stronger
expression of minK in the dog. However, there is a
discrepancy between the Western blot results, showing
a 33% greater expression level in the dog (Table 1),
and the immunofluorescence results (Fig. 8), showing
an approximately 5-fold greater expression in canine
cardiomyocytes. In addition, if minK overexpression were
responsible for greater IKs in the dog, kinetics should have
differed markedly between the species, which they do not.
Therefore, while differences in minK may be involved
in the species differences in IKs, other factors are likely
involved and should be addressed in future work.
Conclusions
Human ventricular cardiomyocytes have reduced
repolarization reserve compared to dog. The differential
response occurs despite similar IKr densities, due to lower
IK1 and IKs densities in human hearts. The underlying
molecular basis appears to be differential expression
of Kir2.x and minK subunits between human and
canine hearts. These results suggest that the protection
afforded by IK1 and IKs against repolarization stress
is limited in humans, making humans susceptible to
excess repolarization impairment from IKr blocking
agents. Animal models are widely used to study cardiac
pathophysiology and pharmacological responses. Our
findings highlight the importance of caution when
extrapolating results from animal models to man, even
from species as apparently similar in ionic current
mechanisms as dogs.
References
Abi-Gerges N, Holkham H, Jones EM, Pollard CE, Valentin JP
& Robertson GA (2011). hERG subunit composition
determines differential drug sensitivity. Br J Pharmacol 164,
419–432.
Biliczki P, Vir´
ag L, Iost N, Papp JGy & Varr ´
o A (2002).
Interaction of different potassium channels in cardiac
repolarization in dog ventricular preparations: role of the
repolarization reserve. Br J Pharmacol 137, 361–368.
Birinyi P, Acsai K, B´
any´
asz T, T ´
oth A, Horv´
ath B, Vir´
ag L,
Szentandr´
assy N, Magyar J, Varr ´
oA,F
¨
ul¨
op F & N´
an´
asi PP
(2005). Effects of SEA0400 and KB-R7943 on Na+/Ca2+
exchange current and L-type Ca2+current in canine
ventricular cardiomyocytes. Naunyn Schmiedebergs Arch
Pharmacol 372, 63–70.
Brendorp B, Elming H, Jun L, Kober L, Malik M, Jensen GB &
Torp-Pedersen C (2001). The DIAMOND Study Group. QTc
interval as a guide to select those patients with congestive
heart failure and reduced left ventricular systolic function
who will benefit from antiarrhythmic treatment with
dofetilide. Circulation 103, 1422–1427.
Dhamoon AS & Jalife J (2005). The inward rectifier current
(IK1) controls cardiac excitability and is involved in
arrhythmogenesis. Heart Rhythm 2, 316–324.
Dhamoon AS, Pandit SV, Sarmast F, Parisian KR, Guha P, Li Y,
Bagwe S, Taffet SM & Anumonwo JM (2004). Unique Kir2.x
properties determine regional and species differences in the
cardiac inward rectifier K+current. Circ Res 94, 1332–1339.
Dumaine R & Cordeiro JM (2007). Comparison of K+currents
in cardiac Purkinje cells isolated from rabbit and dog. JMol
Cell Cardiol 42, 378–389.
El-Sherif N (1992). The proarrhythmic mechanism of drugs
that prolong repolarisation. Role of early afterdepolarisation.
New Trends in Arrhythmias 8, 617–626.
Fang Y, Schram G, Romanenko VG, Shi C, Conti L,
Vandenberg CA, Davies PF, Nattel S & Levitan I (2005).
Functional expression of Kir2.x in human aortic endothelial
cells: the dominant role of Kir2.2. Am J Physiol Cell Physiol
289, C1134–C1144.
Fuller W, Tulloch LB, Shattock MJ, Calaghan SC, Howie J &
Wypijewski KJ (2013). Regulation of the cardiac sodium
pump. Cell Mol Life Sci 70, 1357–1380.
Hobai IA, Khananshvili D & Levi AJ (1997). The peptide
“FRCRCFa”, dialysed intracellularly, inhibits the Na/Ca
exchange in rabbit ventricular myocytes with high affinity.
Pflugers Arch 33, 455–463.
Hohnloser SH & Woosley R (1994). Sotalol. New Engl J
Medicine 331, 31–38.
Hondeghem LM & Snyders DJ (1990). Class III antiarrhythmic
agents have a lot of potential but a long way to go. Reduced
effectiveness and dangers of reverse use dependence.
Circulation 81, 686–690.
Hund TJ & Rudy Y (2004). Rate dependence and regulation of
action potential and calcium transient in a canine cardiac
ventricular cell model. Circulation 110, 3168–3174.
Jost N, Vir ´
ag L, Bitay M, Tak ´
acs J, Lengyel C, Biliczki P, Nagy Z,
Bog´
ats G, Lathrop DA, Papp JG & Varr ´
o A (2005).
Restricting excessive cardiac action potential and QT
prolongation: a vital role for IKs in human ventricular
muscle. Circulation 112, 1392–1399.
Larsen AP & Olesen SP (2010). Differential expression of
hERG1 channel isoforms reproduces properties of native
I(Kr) and modulates cardiac action potential characteristics.
PLoS One 5, e9021.
Lengyel Cs, Iost N, Vir´
ag L, Varr ´
o A, Lathrop AD & Papp JGy
(2001). Pharmacological block of the slow component of the
outward delayed rectifier current (IKs) fails to lengthen
rabbit ventricular muscle QTcand action potential duration.
Br J Pharmacol 132, 101–110.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
J Physiol 591.17 Weak IK1,IKs limit human repolarization reserve 4205
Lesage F & Lazdunski M (2000). Molecular and functional
properties of two-pore-domain potassium channels. Am J
Physiol Renal Physiol 279, F793–F801.
Lopatin AN & Nichols CG (2001). Inward rectifiers in the
heart: an update on IK1 (review). JMolCellCardiol33,
625–638.
Lu HR, Mari¨
en R, Saels A & De Clerck F (2001). Species plays
an important role in drug-induced prolongation of action
potential duration and early afterdepolarizations in isolated
Purkinje fibers. J Cardiovasc Electrophysiol 12,
93–102.
Lu Z, Kamiya K, Opthof T, Yasui K & Kodama I (2001). Density
and kinetics of IKr and IKs in guinea pig and rabbit
ventricular myocytes explain different efficacy of IKs
blockade at high heart rate in guinea pig and rabbit:
implications for arrhythmogenesis in humans. Circulation
104, 951–956.
Maguy A, Le Bouter S, Comtois P, Chartier D, Villeneuve L,
Wakili R, Nishida K & Nattel S (2009). Ion channel subunit
expression changes in cardiac Purkinje fibers: a potential role
in conduction abnormalities associated with congestive heart
failure. Circ Res 104, 1113–1122.
Melnyk P, Zhang L, Shrier A & Nattel S (2002). Differential
distribution of Kir2.1 and Kir2.3 subunits in canine atrium
and ventricle. Am J Physiol Heart Circ Physiol 283,
H1123H1133.
Nerbonne M & Kass RS (2005). Molecular physiology of
cardiac repolarization. Physiol Rev 85, 1205–1253.
O’Hara T, Vir´
ag L, Varr ´
o A & Rudy Y (2011). Simulation of the
undiseased human cardiac ventricular action potential:
model formulation and experimental validation. PLoS
Comput Biol 7(5), e1002061.
Pfaffl WM (2001). A new mathematical model for relative
quantification in real-time RT-PCR. Nucleic Acids Res 29,
2002–2007.
Pourrier M, Schram G & Nattel S (2003). Properties,
Expression and Potential Roles of Cardiac K+Channel
Accessory Subunits: MinK, MiRPs, KChIP, and KChAP.
JMembraneBiol194, 141–152.
Roden DM (1998). Taking the “idio” out of “idiosyncratic”:
Predicting torsades de pointes. PACE 21, 1029–1034.
Roden DM (2006). Long QT syndrome: reduced repolarization
reserveandthegeneticlink.JInternMed259,
59–69.
Sale H, Wang J, O’Hara TJ, Tester DJ, Phartiyal P, He JQ, Rudy
Y, Ackerman MJ & Robertson GA (2008). Physiological
properties of hERG 1a/1b heteromeric currents and a hERG
1b-specific mutation associated with Long-QT syndrome.
Circ Res 103, e81–e95.
Schram G, Pourrier M, Wang Z, White M & Nattel S (2003).
Barium block of Kir2 and human cardiac inward rectifier
currents: Evidence for subunit-heteromeric contribution to
native currents. Cardiovasc Res,59, 328–338.
Shimizu W & Antzelevitch C (1999). Cellular basis for long QT,
transmural dispersion of repolarization, and torsade de
pointes in the long QT syndrome. JElectrocardiol32,
177–184.
Silva J & Rudy Y (2005). Subunit interaction determines IKs
participation in cardiac repolarization and repolarization
reserve. Circulation 112, 1384–1391.
Singh BN & Vaughan-Williams EM (1970). A third class of
anti-arrhythmic action. Effects on atrial and ventricular
intracellular potentials, and other pharmacological actions
on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol
39, 675–687.
Surawicz B (1989). Electrophysiologic substrate of Torsade de
Pointes: Dispersion of repolarisation or early
afterdepolarisation? J Am Coll Cardiol 14, 172–184.
T´
oth A, Kiss L, Varr´
oA&N
´
an´
asi PP (2009). Potential
therapeutic effects of Na+/Ca2+exchanger inhibition in
cardiac diseases. Current Medicinal Chemistry,16,
3294–3321.
Tsuboi M & Antzelevitch C (2006). Cellular basis for
electrocardiographic and arrhythmic manifestations of
Andersen-Tawil syndrome (LQT7). Heart Rhythm 3,
328–335.
Vargas HM, Bass AS, Breidenbach A, Feldman HS, Gintant GA,
Harmer AR, Heath B, Hoffmann P, Lagrutta A, Leishman D,
McMahon N, Mittelstadt S, Polonchuk L, Pugsley MK, Salata
JJ & Valentin JP (2008). Scientific review and
recommendations on preclinical cardiovascular safety
evaluation of biologics. J Pharmacol Toxicol Methods 58,
72–76.
Varr ´
oA,Bal
´
ati B, Iost N, Tak ´
acs J, Vir´
ag L, Lathrop DA,
Lengyel C, T´
alosi L & Papp JGy (2000). The role of the
delayed rectifier component IKs in dog ventricular muscle
and Purkinje fibre repolarization. JPhysiol523, 67–81.
Wang Z, Yue L, White M, Pelletier G & Nattel S (1998).
Differential distribution of inward rectifier potassium
channel transcripts in human atrium versus ventricle.
Circulation 98, 2422–2428.
Yan DH, Nishimura K, Yoshida K, Nakahira K, Ehara T,
Igarashi K & Ishihara K (2005). Different intracellular
polyamine concentrations underlie the difference in the
inward rectifier K+currents in atria and ventricles of the
guinea-pig heart. JPhysiol 563, 713–724.
ZichaS,MossI,AllenB,VarroA,PappJ,DumaineR,
Antzelevich C & Nattel S (2003). Molecular basis of
species-specific expression of repolarizing K+currents in the
heart. Am J Physiol Heart Circ Physiol 285, H1641–H1649.
Zobel C, Cho HC, Nguyen TT, Pekhletski R, Diaz RJ, Wilson
GJ & Backx PH (2003). Molecular dissection of the inward
rectifier potassium current (IK1) in rabbit cardiomyocytes:
evidence for heteromeric co-assembly of Kir2.1 and Kir2.2.
JPhysiol550, 365–372.
Additional information
Conflict of interest
None declared.
Author contributions
Conception and design of the experiments: N.J., L.V., J.Gy.P.,
A.V., S.N.; collection, analysis and interpretation of data: N.J.,
L.V., P.C., B. ¨
O., V.Sz., Gy.S., M.B., Zs.K., I.K., N.N., T.Sz., J.M.,
M.K., L.G.P., Cs.L., A.V., S.N.; drafting the article and revising
it critically for intellectual content: N.J., L.V., P.C., B. ¨
O., V.Sz.,
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
4206 N. Jost and others J Physiol 591.17
Gy.S., J.M., L.G.P., E.W., U.R., P.P.N., J.Gy.P., A.V., S.N. All
authors approved the final version of the manuscript.
Funding
This work was supported by grants from the Hungarian Scientific
Research Fund (CNK-77855, K-82079 and NK-104331), the
National Office for Research and Technology-Baross
Programmes (REG-DA-09-2-2009-0115-NCXINHIB), the
National Development Agency and co-financed by the European
Regional Fund (T ´
AMOP-4.2.2/B-10/1-2010-0012; T ´
AMOP-
4.2.2.A-11/1/KONV-2012-0035; T ´
AMOP-4.2.2A-11/1/KONV-
2012-0073 and T ´
AMOP-4.2.2.A-11/1/KONV-2012-0060), the
Hungarian Academy of Sciences, the Canadian Institutes for
Health Care Research (MOP 68929), German Hungarian
Research Cooperation DFG Grant (436 UNG 113/176/0-1)
HU-RO Cross-Border Cooperation Programmes (HURO/0802/
011_AF-HURO_CARDIOPOL and HURO/1001/086/2.2.1_
HURO-TWIN,) and the Hungarian Academy of Sciences.
Acknowledgements
The authors thank France Th´
eriault for secretarial help with the
manuscript.
C
2013 The Authors. The Journal of Physiology C
2013 The Physiological Society
... Computational modeling and simulations, now commonly used in the drug development pipelines (44), have proven useful for integrating species-specific experimental data into comprehensive mathematical models of mouse (28,45), rat (46), guinea pig (47), rabbit (48), dog (49), and human ventricular myocytes (32,50,51). For many years, implications of interspecies differences have been investigated simulating these models (21,42,52), or integrating simulations into the experimental activity, as in the case of the dynamic clamp technique (20,53). ...
... S6, B and C). Translating the effects of selective block of I K1(38,42) and I CaL (41) also yielded good predictions(fig. S7). ...
Article
Full-text available
Animal experimentation is key in the evaluation of cardiac efficacy and safety of novel therapeutic compounds. However, interspecies differences in the mechanisms regulating excitation-contraction coupling can limit the translation of experimental findings from animal models to human physiology and undermine the assessment of drugs’ efficacy and safety. Here, we built a suite of translators for quantitatively mapping electrophysiological responses in ventricular myocytes across species. We trained these statistical operators using a broad dataset obtained by simulating populations of our biophysically detailed computational models of action potential and Ca2+ transient in mouse, rabbit, and human. We then tested our translators against experimental data describing the response to stimuli, such as ion channel block, change in beating rate, and β-adrenergic challenge. We demonstrate that this approach is well suited to predicting the effects of perturbations across different species or experimental conditions and suggest its integration into mechanistic studies and drug development pipelines.
... The main reason lies in the fact that, even in human ventricular myocytes, repolarizing potassium outward currents are very small and difficult to detect. Delayed rectifier K + channel currents in adult human cardiac myocytes amount to less than 1 pA/pF (Jost et al., 2013) or remained undetectable [for detailed discussion compare (Ma et al., 2011)]. Moretti et al. (2010) were the first to demonstrate slow delayed rectifier currents (I Ks ) in hiPSC-CM. ...
Article
Full-text available
Models based on human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) are proposed in almost any field of physiology and pharmacology. The development of human induced pluripotent stem cell-derived cardiomyocytes is expected to become a step forward to increase the translational power of cardiovascular research. Importantly they should allow to study genetic effects on an electrophysiological background close to the human situation. However, biological and methodological issues revealed when human induced pluripotent stem cell-derived cardiomyocytes were used in experimental electrophysiology. We will discuss some of the challenges that should be considered when human induced pluripotent stem cell-derived cardiomyocytes will be used as a physiological model.
... As a result, the AP plateau and the APD adaptation also presented a better agreement with human experimental data than previous electrophysiological models. A 5-fold increase in the basal levels of the I Ks conductance was applied following the observations reported in different human electrophysiological studies [20,21], that show I Ks current values 5-fold times bigger than those originally reported in the model. ...
Article
Full-text available
Hypertrophic cardiomyopathy (HCM) patients often present an enhanced arrhythmogenicity that can lead to lethal arrhythmias, especially during exercise. Recent studies have indicated an abnormal response of HCM cardiomyocytes to β-adrenergic receptor stimulation (β-ARS), with prolongation of their action potential rather than shortening. The mechanisms underlying this aberrant response to sympathetic stimulation and its possible proarrhythmic role remain unknown. The aims of this study are to investigate the key ionic mechanisms underlying the HCM abnormal response to β-ARS and the resultant repolarisation abnormalities using human-based experimental and computational methodologies. We integrated and calibrated the latest models of human ventricular electrophysiology and β-ARS using experimental measurements of human adult cardiomyocytes from control and HCM patients. Our major findings include: (1) the developed in silico models of β-ARS capture the behaviour observed in the experimental data, including the aberrant response of HCM cardiomyocytes to β-ARS; (2) the reduced increase of potassium currents under β-ARS was identified as the main mechanism of action potential prolongation in HCM, rather than a more sustained inward calcium current; (3) action potential duration differences between healthy and HCM cardiomyocytes were increased upon β-ARS, while endocardial to epicardial differences in HCM cardiomyocytes were reduced; (4) models presenting repolarisation abnormalities were characterised by downregulation of the rapid delayed rectifier potassium current and the sodium‑potassium pump, while inward currents were upregulated. In conclusion, our results identify causal relationships between the HCM phenotype and its arrhythmogenic response to β-ARS through the downregulation of potassium currents.
... This has its origin in the average conscious resting heart rate is lower in guinea pigs, and ventricular action potentials exhibit a distinct plateau phase unlike in smaller rodents (Farraj et al. 2011). Also, ionic currents and QT interval characteristics are similar to those of larger non-rodent laboratory animals (e.g., rabbit, dog) with a significant translational value to the human heart (Jost et al. 2013;Baczko et al. 2016;Nanasi et al. 2021). In addition, the primary repolarizing ionic currents in guinea pig hearts are I Ks and I Kr (Farraj et al. 2011;OʼHara and Rudy 2012) and which have an uncertain role in rats or mice; however, the main repolarizing transmembrane ionic currents in the human myocardium that are thought to be damaged because of heavy long-term exercise. ...
Article
Besides the health benefits of regular exercise, high-level training - above an optimal level -may have adverse effects. In this study, we investigated the effects of long-term vigorous training and its potentially detrimental structural-functional changes in a small animal athlete’s heart model. Thirty-eight 4-month-old male guinea pigs were randomised into sedentary and exercised groups. The latter underwent a 15-week-long endurance-training program. To investigate the effects of the intense long-term exercise, in vivo (echocardiography, electrocardiography), ex vivo and in vitro (histopathology, patch-clamp) measurements were performed. Following the training protocol, the exercised animals exhibited structural left ventricular enlargement and significantly higher degree of myocardial fibrosis. Furthermore, resting bradycardia accompanied by elevated heart rate variability occurred, representing increased parasympathetic activity in the exercised hearts. The observed prolonged QTc intervals and increased repolarization variability parameters may raise the risk of electrical instability in exercised animals. Complex arrhythmias did not occur in either group and there were no differences between the groups in ex vivo or in cellular electrophysiological experiments. Accordingly, the high parasympathetic activity may promote impaired repolarization in conscious exercised animals. The detected structural-functional changes share similarities with the human athlete’s heart, therefore, this model might be useful for investigations on cardiac remodeling.
Article
Full-text available
The health benefits of regular physical exercise are well known. Even so, there is increasing evidence that the exercise regimes of elite athletes can evoke cardiac arrhythmias including ventricular fibrillation and even sudden cardiac death (SCD). The mechanism of exercise-induced arrhythmia and SCD is poorly understood. Here, we show that chronic training in a canine model (12 sedentary and 12 trained dogs) that mimics the regime of elite athletes induces electrophysiological remodeling (measured by ECG, patch-clamp and immunocytochemical techniques) resulting in increases of both the trigger and the substrate for ventricular arrhythmias. Thus, 4 months sustained training lengthened ventricular repolarization (QTc: 237.1±3.4 ms vs. 213.6±2.8 ms, n=12; APD90: 472.8±29.6 ms vs. 370.1±32.7 ms, n=29 vs. 25), decreased transient outward potassium current (6.4±0.5 pA/pF vs. 8.8±0.9 pA/pF at 50 mV, n=54 vs. 42) and increased the short term variability of repolarization (29.5±3.8 ms vs. 17.5±4.0 ms, n=27 vs. 18). Left ventricular fibrosis and HCN4 protein expression were also enhanced. These changes were associated with enhanced ectopic activity (number of escape beats from 0/hour to 29.7±20.3/hour) in vivo and arrhythmia susceptibility (elicited ventricular fibrillation: 3 of 10 sedentary dogs vs. 6 of 10 trained dogs). Our findings provide in vivo, cellular electrophysiological and molecular biological evidence for the enhanced susceptibility to ventricular arrhythmia in an experimental large animal model of endurance training.
Article
Introduction Impaired IKs induced by drugs or due to a KCNQ1 mutation, diagnosed as long QT syndrome type 1 (LQT1) prolongs the QT interval and predisposes the heart to Torsade de Pointes (TdP) arrhythmias. The anesthetized chronic AV block (CAVB) dog is inducible for TdP after remodeling and IKr inhibitor dofetilide. We tested the proarrhythmic effect of IKs inhibition in the CAVB dog, and the proarrhythmic role of increased contractility herein. Methods Dofetilide-inducible animals were included to test the proarrhythmic effect of 1) IKs inhibition by JNJ303 (0.63 mg/kg/10min i.v.; n = 4), 2) IKs inhibition combined with enhanced inotropy (ouabain, 0.045 mg/kg/1min i.v.; n = 6), and 3) the washout period of the anesthetic regime (n = 10). Results JNJ303 prolonged the QTc interval (from 477 ± 53 ms to 565 ± 14 ms, P < 0.02) resembling standardized dofetilide-induced QTc prolongation. Single ectopic beats (n = 4) and ventricular tachycardia (VT) (n = 3) were present, increasing the arrhythmia score (AS) from 1.0 ± 0 to 7.1 ± 6.5. JNJ303 combined with ouabain increased contractile parameters (LVdP/dtmax from 1725 ± 273 to 4147 ± 611 mmHg/sec, P < 0.01). Moreover, TdP arrhythmias were induced in 4/6 dogs and AS increased from 1.0 ± 0 to 20.2 ± 19.0 after JNJ303 and ouabain (P < 0.05). Finally, TdP arrhythmias were induced in 4/10 dogs during the anesthesia washout period and the AS increased from 1.1 ± 0.3 to 9.2 ± 11.2. Conclusion Mimicking LQT1 using IKs inhibitor JNJ303 prolongs the QTc interval and triggers ectopic beats and non-sustained VT in the CAVB dog. Induction of the more severe arrhythmic events (TdP) demands a combination of IKs inhibition with enhanced inotropy or ending the anesthetic regime.
Chapter
This chapter considers mechanisms of torsades de pointes (TdP) linked to delayed ventricular repolarization. Major ionic conductances contributing to action potential repolarization are summarized. The key role of IKr as an anti-target in drug-induced long QT syndrome (diLQTS) is considered, as is more recent evidence implicating late Na current (INa,L) enhancement as an additional mechanism by which chronic drug exposure can prolong ventricular action potentials. Factors influencing repolarization reserve, heterogeneity (dispersion) of repolarization and formation of early afterdepolarizations (EADs) are described. Evidence for TdP triggers and maintenance mechanisms from models of congenital LQTS variants 1–3 is discussed. Models of and issues pertaining to evaluation of TdP in diLQTS are then considered, including the use of surrogate measures as exemplified by the TRiAD model. Across the different forms of LQTS considered, EADs are strongly implicated as trigger events for TdP, whilst dispersion of repolarization is a likely maintenance substrate.
Article
The fast transient outward potassium current (Ito,f) plays a key role in phase 1 repolarization of the human cardiac action potential (AP) and its reduction in heart failure (HF) contributes to the loss of contractility. Therefore, restoring Ito,f might be beneficial for treating HF. The coding sequence of a P2A peptide was cloned, in frame, between Kv4.3 and KChIP2.1 genes and ribosomal skipping was confirmed by Western blotting. Typical Ito,f properties with slowed inactivation and accelerated recovery from inactivation due to the association of KChIP2.1 with Kv4.3 was seen in transfected HEK293 cells. Both bicistronic components trafficked to the plasmamembrane and in adenovirus transduced rabbit cardiomyocytes both t-tubular and sarcolemmal construct labelling appeared. The resulting current was similar to Ito,f seen in human ventricular cardiomyocytes and was 50% blocked at ~0.8 mmol/l 4-aminopyridine and increased ~30% by 5 μmol/l NS5806 (an Ito,f agonist). Variation in the density of the expressed Ito,f, in rabbit cardiomyocytes recapitulated typical species-dependent variations in AP morphology. Simultaneous voltage recording and intracellular Ca²⁺ imaging showed that modification of phase 1 to a non-failing human phenotype improved the rate of rise and magnitude of the Ca²⁺ transient. Ito,f expression also reduced AP triangulation but did not affect ICa,L and INa magnitudes. This raises the possibility for a new gene-based therapeutic approach to HF based on selective phase 1 modification.
Article
Full-text available
Cellular electrophysiology experiments, important for understanding cardiac arrhythmia mechanisms, are usually performed with channels expressed in non myocytes, or with non-human myocytes. Differences between cell types and species affect results. Thus, an accurate model for the undiseased human ventricular action potential (AP) which reproduces a broad range of physiological behaviors is needed. Such a model requires extensive experimental data, but essential elements have been unavailable. Here, we develop a human ventricular AP model using new undiseased human ventricular data: Ca(2+) versus voltage dependent inactivation of L-type Ca(2+) current (I(CaL)); kinetics for the transient outward, rapid delayed rectifier (I(Kr)), Na(+)/Ca(2+) exchange (I(NaCa)), and inward rectifier currents; AP recordings at all physiological cycle lengths; and rate dependence and restitution of AP duration (APD) with and without a variety of specific channel blockers. Simulated APs reproduced the experimental AP morphology, APD rate dependence, and restitution. Using undiseased human mRNA and protein data, models for different transmural cell types were developed. Experiments for rate dependence of Ca(2+) (including peak and decay) and intracellular sodium ([Na(+)](i)) in undiseased human myocytes were quantitatively reproduced by the model. Early afterdepolarizations were induced by I(Kr) block during slow pacing, and AP and Ca(2+) alternans appeared at rates >200 bpm, as observed in the nonfailing human ventricle. Ca(2+)/calmodulin-dependent protein kinase II (CaMK) modulated rate dependence of Ca(2+) cycling. I(NaCa) linked Ca(2+) alternation to AP alternans. CaMK suppression or SERCA upregulation eliminated alternans. Steady state APD rate dependence was caused primarily by changes in [Na(+)](i), via its modulation of the electrogenic Na(+)/K(+) ATPase current. At fast pacing rates, late Na(+) current and I(CaL) were also contributors. APD shortening during restitution was primarily dependent on reduced late Na(+) and I(CaL) currents due to inactivation at short diastolic intervals, with additional contribution from elevated I(Kr) due to incomplete deactivation.
Article
Several interventions including a large number of pharmacological agents can cause prolongation of cardiac repolarization. Drugs that prolong cardiac repolarization exhibit strong antiarrhythmic properties as well as pro-arrhythmic effects. One possible mechanism for the pro-arrhythmia is early afterdepolarizations (EADs)-induced triggered arrhythmias. The three steps required for manifestation of EAD-induced triggered activity are: 1) critical prolongation of the repolarization phase, 2) a net depolarizing current carrying the charge for EAD, and 3) propagation of EADs which are locally generated to capture the entire heart resulting in one or more extrasystoles. The majority of pharmacological interventions associated with EADs could be grouped as acting predominantly through one of three different mechanisms: 1) a delay of one or more of potassium currents (I(k), I(k1), and I(to)), 2) an increase of transsarcolemmal calcium current (I(Ca)), and 3) a delay of sodium current (I(Na)) inactivation. The depolarizing charge for EAD could be through the Ca channel, the Na channel, or the electrogenic Na-Ca exchange. A unified concept for the charge carrier of EAD may not be warranted. EAD could be viewed as caused by an imbalance between multiple voltage- and time-dependent inward and outward currents whose magnitudes, voltage and time dependency vary between cell type, species and physiological state.
The Publisher regrets that this article is an accidental duplication of an article that has already been published, doi: 10.1016/j.vascn.2008.04.001 . The duplicate article has therefore been withdrawn.
Article
In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of active transport at the myocyte cell surface, and its activity is essential for maintaining the trans-sarcolemmal sodium gradient that drives ion exchange and transport processes that are critical for cardiac function. The 72-residue phosphoprotein phospholemman regulates the sodium pump in the heart: unphosphorylated phospholemman inhibits the pump, and phospholemman phosphorylation increases pump activity. Phospholemman is subject to a remarkable plethora of post-translational modifications for such a small protein: the combination of three phosphorylation sites, two palmitoylation sites, and one glutathionylation site means that phospholemman integrates multiple signaling events to control the cardiac sodium pump. Since misregulation of cytosolic sodium contributes to contractile and metabolic dysfunction during cardiac failure, a complete understanding of the mechanisms that control the cardiac sodium pump is vital. This review explores our current understanding of these mechanisms. Electronic supplementary material The online version of this article (doi:10.1007/s00018-012-1134-y) contains supplementary material, which is available to authorized users.
Article
 We investigated the effect in rabbit ventricular myocytes of ”FRCRCFa”, a newly developed peptide inhibitor of the Na/Ca exchange. Myocytes were whole-cell patch clamped and experiments were carried out at 36°C. The Na/Ca exchange was measured selectively, by blocking interfering ion channel currents and the Na/K pump, as the membrane current which could be inhibited by 5 mM nickel (Ni; a known blocker of the Na/Ca exchange). Increasing concentrations of FRCRCFa dialysed into the cell from the patch-pipette inhibited the Na/Ca exchange current. The dose/response curve could be fitted by a function for co-operative ligand binding, which predicted a KD for FRCRCFa-mediated inhibition of 22.7 ± 3.7 nM, with a Hill coefficient of 0.61 ± 0.06. Pipette FRCRCFa concentrations of 1 μM and above were sufficient to cause complete inhibition of Na/Ca exchange current. The inhibitory effect of FRCRCFa was independent of membrane potential and relatively selective: 10 μM FRCRCFa dialysed into the cell had no effect on the L-type Ca current and delayed rectifier and inward rectifier K currents. Thus FRCRCFa appears to be a potent and relatively selective inhibitor of the Na/Ca exchange in intact cardiac myocytes, and may be of value for studies of the Na/Ca exchange.
Article
Biological therapeutic agents (biologicals), such as monoclonal antibodies (mAbs), are increasingly important in the treatment of human disease, and many types of biologicals are in clinical development. During preclinical drug development, cardiovascular safety pharmacology studies are performed to assess cardiac safety in accord with the ICH S7A and S7B regulations that guide these studies. The question arises, however, whether or not it is appropriate to apply these guidelines, which were devised primarily to standardize small molecule drug testing, to the cardiovascular evaluation of biologicals. We examined the scientific literature and formed a consensus of scientific opinion to determine if there is a rational basis for conducting an in vitro hERG assay as part of routine preclinical cardiovascular safety testing for biologicals. We conclude that mAb therapeutics have very low potential to interact with the extracellular or intracellular (pore) domains on hERG channel and, therefore, are highly unlikely to inhibit hERG channel activity based on their targeted, specific binding properties. Furthermore, mAb are large molecules (> 140,000 Da) that cannot cross plasma membranes and therefore would be unable to access and block the promiscuous inner pore of the hERG channel, in contrast with typical small molecule drugs. Consequently, we recommend that it is not appropriate to conduct an in vitro hERG assay as part of a preclinical strategy for assessing the heart rate corrected QT interval (QTc) prolongation risk of mAbs and other types of biologicals. It is more appropriate to assess QTc risk by integrating cardiovascular endpoints into repeat-dose general toxicology studies performed in an appropriate non-rodent species. These recommendations should help shape future regulatory strategy and discussions for the cardiovascular safety pharmacology testing of mAbs as well as other biologicals and provide guidance for the preclinical cardiovascular evaluation of such agents.
Article
Two characteristic features of the rapid component of the cardiac delayed rectifier current (IKr) are prominent inward rectification and an unexpected reduction in activating current with decreased [K+]o. Similar features are observed with heterologous expression of HERG, the gene thought to encode the channel carrying IKr, moreover, recent studies indicate that the mechanism underlying rectification of HERG current is the inactivation that channels rapidly undergo during depolarizing pulses. The present studies were designed to determine the mechanism of IKr rectification and [K+]o sensitivity in the mouse atrial myocyte cell line, AT-1 cells. Reducing [Mg2+]i to 0, which reverses inward rectification of some K+ channels, did not alter IKr current-voltage relationships, although it did decrease sensitivity to the IKr blockers dofetilide and quinidine 2- to 5-fold. To determine the presence and extent of fast inactivation of IKr in AT-1 cells, a brief hyperpolarizing pulse (20 ms to -120 mV) was applied during long depolarizations. Immediately after this pulse, a very large outward current that decayed rapidly to the previous activating current baseline was observed. This outward current component was blocked by the IKr-specific inhibitor dofetilide, indicating that it represented recovery from fast inactivation during the hyperpolarizing step, with fast reinactivation during the return to depolarized potential. With removal of inactivation using this approach, current-voltage relationships for IKr ([K+]o, 1 to 20 mmol/L) were linar and reversed close to the predicted Nernst potential for K+. In addition, decreased [K+]o decreased the time constants for open-->inactivated and inactivated-->open transitions. Thus, in these cardiac myocytes, as with heterologously expressed HERG, IKr undergoes fast inactivation that determines its characteristic inward rectification. These studies demonstrate that the mechanism underlying decreased activating current observed at low [K+]o is more extensive fast inactivation.
Article
The aim of the present study was to give a parametric description of the most important K(+) currents flowing during canine ventricular action potential. Inward rectifier K(+) current (I(K1)), rapid delayed rectifier K(+) current (I(Kr)), and transient outward K(+) current (I(to)) were dissected under action potential clamp conditions using BaCl(2), E-4031, and 4-aminopyridine, respectively. The maximum amplitude of I(to) was 3.0 +/- 0.23 pA/pF and its integral was 29.7 +/- 2.5 fC/pF. The current peaked 4.4 +/- 0.7 ms after the action potential upstroke and rapidly decayed to zero with a time constant of 7.4 +/- 0.6 ms. I(Kr) gradually increased during the plateau, peaked 7 ms before the time of maximum rate of repolarization (V(max)(-)) at -54.2 +/- 1.7 mV, had peak amplitude of 0.62 +/- 0.08 pA/pF, and integral of 57.6 +/- 6.7 fC/pF. I(K1) began to rise from -22.4 +/- 0.8 mV, peaked 1 ms after the time of V(max)(-) at -58.3 +/- 0.6 mV, had peak amplitude of 1.8 +/- 0.1 pA/pF, and integral of 61.6 +/- 6.2 fC/pF. Good correlation was observed between peak I(K1) and V(max)(-) (r = 0.93) but none between I(Kr) and V(max)(-). Neither I(K1) nor I(Kr) was frequency-dependent between 0.2 and 1.66 Hz. Congruently, I(Kr) failed to accumulate in canine myocytes at fast driving rates. Terminal repolarization is dominated by I(K1), but action potential duration is influenced by several ion currents simultaneously. As I(to) was not active during the plateau, and neither I(K1) nor I(Kr) was frequency-dependent, other currents must be responsible for the frequency dependence of action potential duration at normal and slow heart rates in canine ventricular cells.
Article
1. Both MJ 1999 and AH 3474 protected guinea-pigs anaesthetized with urethane against ouabain-induced ventricular fibrillation.2. MJ 1999 had 1/90, and AH 3474 1/30, of the activity of procaine in reducing the height of the action potential of frog sciatic nerve.3. MJ 1999 and AH 3474 reduced the rate of rise of intracellularly recorded action potentials at concentrations in excess of 160 x 10(-6)M (50 mg/l.). It was concluded that direct depression of depolarization could have contributed little to the protection against ouabain-induced fibrillation.4. MJ 1999, but not AH 3474, greatly prolonged the duration of the action potential in acute experiments on isolated atrial and ventricular muscle, and prolonged the Q-Tc interval of the electrocardiogram in anaesthetized guinea-pigs. It is suggested that this effect contributes to anti-arrhythmic activity.5. At concentrations up to 80 x 10(-6)M AH 3474 had positive chronotropic and inotropic effects on isolated rabbit atrial muscle, but at higher concentrations these were superseded by negative effects. MJ 1999 was depressant at all concentrations studied, the threshold concentrations being 19 x 10(-6)M for chronotropic, and 162 x 10(-6)M for inotropic effects.